Generic: copper gluconate
a minerals and electrolyte - treats Age-related macular degeneration, Menkes' kinky-hair disease, Alzheimer's disease prevention, Cardiovascular disease prevention / atherosclerosis, Dental conditions, Metabolic disorders, Immune system function, Marasmus, Neural-tube defect prevention, Osteoporosis / osteopenia, Copper deficiency, Cancer, Schizophrenia, Arthritis, Sideroblastic anemia, Plaque prevention, Systemic lupus erythematosus, and Childhood growth promotion
SafetyDISCLAIMER: Many complementary techniques are practiced by healthcare professionals with formal training, in accordance with the standards of national organizations. However, this is not universally the case, and adverse effects are possible. Due to limited research, in some cases only limited safety information is available.
Side Effects and Warnings
Copper toxicity is rare in the general population. Excess copper consumption may lead to liver, kidney, or neurologic damage. Excess dosing may lead to toxic symptoms including weakness, abdominal pain, nausea, vomiting, and diarrhea, with more serious signs of acute toxicity including liver damage, kidney failure, pleural damage, coma, and death. Other medical problems associated with copper toxicity in studies or anecdotally include anxiety, depression, dizziness, fatigue, headache, learning disabilities, memory lapses, diminished concentration, insomnia, seizure, delirium, stuttering, hyperactivity, arthralgias, myalgias, hypertension, gingivitis, dermatitis, discoloration of skin/ hair, preeclampsia, postpartum psychosis, weight gain, or transaminitis. Acute copper poisoning has occurred through the contamination of beverages by storage in copper containing containers as well as from contaminated water supplies. In the U.S., the health- based guideline for a maximum water copper concentration of 1.3 milligrams per liter has been enforced by the Environmental Protection Agency.
Genetic disorders affecting copper metabolism such as Wilson's disease, Indian childhood cirrhosis, or idiopathic copper toxicosis place individuals at risk of adverse effects of chronic copper toxicity at significantly lower intake levels. Trientine is a copper- chelating agent used in the management of Wilson's disease. Penicillamine has also been used to bind copper and enhance its elimination in Wilson's disease. Zinc in therapeutic dosages has been used to inhibit copper absorption in patients with Wilson's disease. Animal research suggests that supplementation with taurine may reduce toxic effects of copper when given in combination, although it is not clear if this is the case in humans.
Copper- T devices are a type of intrauterine devices (IUD) used for birth control which have been linked to the development of anemia and increased risk of pelvic infection in some users. Copper released from the IUDs may cause hormonal changes and alter the menstrual cycle in women. Other common side effects include pain/ cramps, abnormal bleeding, and device expulsion. In some cases, pelvic inflammatory disease (PID) or anemia may develop.
Pregnancy and Breastfeeding
It is unclear if copper supplementation is necessary during pregnancy to maintain adequate copper levels. Copper is potentially unsafe when used orally in higher doses. Animal studies suggest that trace metal aberrations, including copper, may be related to disturbed fetal growth or teratogenicity, particularly in the setting of diabetic pregnancy.
Copper is potentially unsafe when used orally in higher doses than the RDA. Copper is present in breast milk.